Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.13M Buy
16,942
+12,675
+297% +$4.34M 1.53% 14
2026
Q1
$1.5M Hold
4,267
1.4% 19
2025
Q4
$1.4M Buy
+4,267
New +$1.35M 1.36% 18
2025
Q2
$1.23M Sell
4,417
-363
-8% -$103K 1.22% 22
2025
Q1
$1.49M Buy
4,780
+73
+2% +$21.6K 0.97% 26
2024
Q4
$1.23M Sell
4,707
-120
-2% -$35.6K 0.79% 29
2024
Q3
$1.55M Hold
4,827
1.04% 21
2024
Q2
$1.51M Sell
4,827
-61
-1% -$17.9K 1.08% 20
2024
Q1
$1.39M Buy
+4,888
New +$1.43M 1.05% 22

Other funds holding AMGN

Wealth Group's AMGN Position: Q2 2026 in Review

Wealth Group increased its Amgen (AMGN) stake by 297% in Q2 2026, buying an estimated $4.34M and bringing the position to 16,942 shares worth $6.13M. The position accounts for 1.53% of the portfolio, ranked #14.

Wealth Group first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wealth Group held 16,942 shares of Amgen worth $6.13M as of Q2 2026.
  • Wealth Group bought 12,675 Amgen shares in Q2 2026, an estimated $4.34M.
  • Amgen made up 1.53% of Wealth Group's portfolio in Q2 2026, its #14 holding.
  • Wealth Group first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.